nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—Etoposide—brain cancer	0.136	0.302	CbGbCtD
Betamethasone—CYP3A4—Temozolomide—brain cancer	0.131	0.291	CbGbCtD
Betamethasone—CYP3A4—Lomustine—brain cancer	0.111	0.247	CbGbCtD
Betamethasone—ABCB1—Etoposide—brain cancer	0.0449	0.0997	CbGbCtD
Betamethasone—CYP3A4—Etoposide—brain cancer	0.0269	0.0598	CbGbCtD
Betamethasone—PLA2G1B—blood vessel—brain cancer	0.0111	0.094	CbGeAlD
Betamethasone—Fluocinonide—SMO—brain cancer	0.0058	0.907	CrCbGaD
Betamethasone—NR3C2—hindbrain—brain cancer	0.00523	0.0444	CbGeAlD
Betamethasone—PGR—blood vessel—brain cancer	0.0051	0.0432	CbGeAlD
Betamethasone—PGR—hindbrain—brain cancer	0.00486	0.0412	CbGeAlD
Betamethasone—PLA2G1B—pituitary gland—brain cancer	0.00437	0.0371	CbGeAlD
Betamethasone—PLA2G1B—endocrine gland—brain cancer	0.00339	0.0287	CbGeAlD
Betamethasone—PLA2G1B—head—brain cancer	0.00335	0.0284	CbGeAlD
Betamethasone—PLA2G1B—central nervous system—brain cancer	0.00305	0.0259	CbGeAlD
Betamethasone—NR3C2—brainstem—brain cancer	0.003	0.0254	CbGeAlD
Betamethasone—NR3C1—hindbrain—brain cancer	0.00281	0.0238	CbGeAlD
Betamethasone—PTGS2—endothelium—brain cancer	0.00276	0.0234	CbGeAlD
Betamethasone—NR3C2—telencephalon—brain cancer	0.00266	0.0226	CbGeAlD
Betamethasone—PTGS2—blood vessel—brain cancer	0.00255	0.0216	CbGeAlD
Betamethasone—PLA2G1B—brain—brain cancer	0.00242	0.0206	CbGeAlD
Betamethasone—NR3C2—pituitary gland—brain cancer	0.00217	0.0184	CbGeAlD
Betamethasone—NR3C2—medulla oblongata—brain cancer	0.00209	0.0177	CbGeAlD
Betamethasone—PGR—pituitary gland—brain cancer	0.00201	0.0171	CbGeAlD
Betamethasone—Skin exfoliation—Hydroxyurea—brain cancer	0.00199	0.00536	CcSEcCtD
Betamethasone—Petechiae—Temozolomide—brain cancer	0.00198	0.00533	CcSEcCtD
Betamethasone—Extravasation—Carmustine—brain cancer	0.00193	0.0052	CcSEcCtD
Betamethasone—NR3C2—midbrain—brain cancer	0.00191	0.0162	CbGeAlD
Betamethasone—Alopecia—Lomustine—brain cancer	0.00189	0.00507	CcSEcCtD
Betamethasone—NR3C2—spinal cord—brain cancer	0.00186	0.0158	CbGeAlD
Betamethasone—Pulmonary oedema—Hydroxyurea—brain cancer	0.00186	0.005	CcSEcCtD
Betamethasone—CYP19A1—gonad—brain cancer	0.00186	0.0158	CbGeAlD
Betamethasone—Amenorrhoea—Temozolomide—brain cancer	0.00186	0.00499	CcSEcCtD
Betamethasone—Leukocytosis—Carmustine—brain cancer	0.0018	0.00483	CcSEcCtD
Betamethasone—Herpes simplex—Temozolomide—brain cancer	0.00177	0.00476	CcSEcCtD
Betamethasone—Infection—Carboplatin—brain cancer	0.00172	0.00463	CcSEcCtD
Betamethasone—NR3C2—endocrine gland—brain cancer	0.00168	0.0142	CbGeAlD
Betamethasone—Necrosis—Etoposide—brain cancer	0.00166	0.00447	CcSEcCtD
Betamethasone—NR3C2—head—brain cancer	0.00166	0.0141	CbGeAlD
Betamethasone—Sweating increased—Procarbazine—brain cancer	0.00165	0.00444	CcSEcCtD
Betamethasone—Tingling sensation—Etoposide—brain cancer	0.00162	0.00437	CcSEcCtD
Betamethasone—Skin exfoliation—Carmustine—brain cancer	0.00161	0.00434	CcSEcCtD
Betamethasone—NR3C1—brainstem—brain cancer	0.00161	0.0136	CbGeAlD
Betamethasone—Dermatitis bullous—Hydroxyurea—brain cancer	0.00159	0.00427	CcSEcCtD
Betamethasone—Neuropathy—Carmustine—brain cancer	0.00158	0.00426	CcSEcCtD
Betamethasone—ABCB1—blood vessel—brain cancer	0.00157	0.0134	CbGeAlD
Betamethasone—PGR—endocrine gland—brain cancer	0.00156	0.0132	CbGeAlD
Betamethasone—Skin exfoliation—Temozolomide—brain cancer	0.00156	0.00419	CcSEcCtD
Betamethasone—PGR—head—brain cancer	0.00154	0.0131	CbGeAlD
Betamethasone—Neuropathy—Temozolomide—brain cancer	0.00153	0.00412	CcSEcCtD
Betamethasone—NR3C2—central nervous system—brain cancer	0.00151	0.0128	CbGeAlD
Betamethasone—Dry eye—Temozolomide—brain cancer	0.00151	0.00405	CcSEcCtD
Betamethasone—Infection—Lomustine—brain cancer	0.00151	0.00405	CcSEcCtD
Betamethasone—Extravasation—Etoposide—brain cancer	0.0015	0.00402	CcSEcCtD
Betamethasone—Thrombocytopenia—Lomustine—brain cancer	0.00148	0.00399	CcSEcCtD
Betamethasone—Pain—Carboplatin—brain cancer	0.00148	0.00399	CcSEcCtD
Betamethasone—Neuropathy peripheral—Procarbazine—brain cancer	0.00148	0.00398	CcSEcCtD
Betamethasone—NR3C2—cerebellum—brain cancer	0.00148	0.0125	CbGeAlD
Betamethasone—Anorexia—Lomustine—brain cancer	0.00144	0.00389	CcSEcCtD
Betamethasone—NR3C1—telencephalon—brain cancer	0.00143	0.0121	CbGeAlD
Betamethasone—Thrombophlebitis—Carmustine—brain cancer	0.00141	0.00381	CcSEcCtD
Betamethasone—Diabetes mellitus—Carmustine—brain cancer	0.00141	0.00379	CcSEcCtD
Betamethasone—PGR—central nervous system—brain cancer	0.00141	0.0119	CbGeAlD
Betamethasone—CYP19A1—endocrine gland—brain cancer	0.0014	0.0119	CbGeAlD
Betamethasone—CYP19A1—head—brain cancer	0.00139	0.0118	CbGeAlD
Betamethasone—Ulcer—Etoposide—brain cancer	0.00138	0.00371	CcSEcCtD
Betamethasone—PGR—cerebellum—brain cancer	0.00137	0.0117	CbGeAlD
Betamethasone—Body temperature increased—Carboplatin—brain cancer	0.00137	0.00369	CcSEcCtD
Betamethasone—Thrombophlebitis—Temozolomide—brain cancer	0.00137	0.00368	CcSEcCtD
Betamethasone—Haemoglobin—Procarbazine—brain cancer	0.00136	0.00366	CcSEcCtD
Betamethasone—Eye pain—Carmustine—brain cancer	0.00136	0.00365	CcSEcCtD
Betamethasone—Haemorrhage—Procarbazine—brain cancer	0.00135	0.00364	CcSEcCtD
Betamethasone—Hallucination—Procarbazine—brain cancer	0.00135	0.00363	CcSEcCtD
Betamethasone—Injury—Carmustine—brain cancer	0.00133	0.00359	CcSEcCtD
Betamethasone—Decreased appetite—Lomustine—brain cancer	0.00132	0.00355	CcSEcCtD
Betamethasone—Eye pain—Temozolomide—brain cancer	0.00131	0.00353	CcSEcCtD
Betamethasone—PGR—Ovarian Infertility Genes—ESR2—brain cancer	0.00131	0.0243	CbGpPWpGaD
Betamethasone—CYP19A1—central nervous system—brain cancer	0.00127	0.0107	CbGeAlD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—VAV1—brain cancer	0.00126	0.0235	CbGpPWpGaD
Betamethasone—Skin exfoliation—Etoposide—brain cancer	0.00125	0.00335	CcSEcCtD
Betamethasone—PTGS2—telencephalon—brain cancer	0.00124	0.0105	CbGeAlD
Betamethasone—Neuropathy—Etoposide—brain cancer	0.00123	0.0033	CcSEcCtD
Betamethasone—Arrhythmia—Procarbazine—brain cancer	0.00121	0.00326	CcSEcCtD
Betamethasone—NR3C2—brain—brain cancer	0.0012	0.0102	CbGeAlD
Betamethasone—Body temperature increased—Lomustine—brain cancer	0.0012	0.00322	CcSEcCtD
Betamethasone—Alopecia—Procarbazine—brain cancer	0.0012	0.00322	CcSEcCtD
Betamethasone—Oesophagitis—Etoposide—brain cancer	0.00119	0.00321	CcSEcCtD
Betamethasone—Weight increased—Hydroxyurea—brain cancer	0.00119	0.00321	CcSEcCtD
Betamethasone—NR3C1—gonad—brain cancer	0.00119	0.0101	CbGeAlD
Betamethasone—Affect lability—Temozolomide—brain cancer	0.00117	0.00314	CcSEcCtD
Betamethasone—NR3C1—pituitary gland—brain cancer	0.00116	0.00986	CbGeAlD
Betamethasone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00114	0.00308	CcSEcCtD
Betamethasone—PGR—Nuclear Receptors—ESR2—brain cancer	0.00114	0.0212	CbGpPWpGaD
Betamethasone—Mood swings—Temozolomide—brain cancer	0.00112	0.00302	CcSEcCtD
Betamethasone—NR3C1—medulla oblongata—brain cancer	0.00112	0.00951	CbGeAlD
Betamethasone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00112	0.0208	CbGpPWpGaD
Betamethasone—PGR—brain—brain cancer	0.00112	0.00947	CbGeAlD
Betamethasone—Hypokalaemia—Carmustine—brain cancer	0.00111	0.003	CcSEcCtD
Betamethasone—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00111	0.0206	CbGpPWpGaD
Betamethasone—Dry skin—Temozolomide—brain cancer	0.00108	0.00292	CcSEcCtD
Betamethasone—Muscular weakness—Carmustine—brain cancer	0.00108	0.00291	CcSEcCtD
Betamethasone—Hypokalaemia—Temozolomide—brain cancer	0.00108	0.0029	CcSEcCtD
Betamethasone—Syncope—Procarbazine—brain cancer	0.00106	0.00285	CcSEcCtD
Betamethasone—Haemoglobin—Hydroxyurea—brain cancer	0.00105	0.00284	CcSEcCtD
Betamethasone—Haemorrhage—Hydroxyurea—brain cancer	0.00105	0.00282	CcSEcCtD
Betamethasone—Cardiac failure congestive—Etoposide—brain cancer	0.00104	0.00281	CcSEcCtD
Betamethasone—Muscular weakness—Temozolomide—brain cancer	0.00104	0.00281	CcSEcCtD
Betamethasone—Hallucination—Hydroxyurea—brain cancer	0.00104	0.00281	CcSEcCtD
Betamethasone—Loss of consciousness—Procarbazine—brain cancer	0.00104	0.00279	CcSEcCtD
Betamethasone—NR3C1—midbrain—brain cancer	0.00102	0.00869	CbGeAlD
Betamethasone—Convulsion—Procarbazine—brain cancer	0.00102	0.00275	CcSEcCtD
Betamethasone—Hypertension—Procarbazine—brain cancer	0.00102	0.00274	CcSEcCtD
Betamethasone—PTGS2—pituitary gland—brain cancer	0.00101	0.00853	CbGeAlD
Betamethasone—CYP19A1—brain—brain cancer	0.001	0.00852	CbGeAlD
Betamethasone—Myalgia—Procarbazine—brain cancer	0.001	0.0027	CcSEcCtD
Betamethasone—Anxiety—Procarbazine—brain cancer	0.001	0.00269	CcSEcCtD
Betamethasone—NR3C1—spinal cord—brain cancer	0.001	0.00848	CbGeAlD
Betamethasone—Sweating increased—Temozolomide—brain cancer	0.000997	0.00268	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Etoposide—brain cancer	0.000979	0.00263	CcSEcCtD
Betamethasone—Cardiac failure—Etoposide—brain cancer	0.000971	0.00261	CcSEcCtD
Betamethasone—PTGS2—medulla oblongata—brain cancer	0.00097	0.00823	CbGeAlD
Betamethasone—Vomiting—Lomustine—brain cancer	0.000964	0.00259	CcSEcCtD
Betamethasone—Oedema—Procarbazine—brain cancer	0.000962	0.00259	CcSEcCtD
Betamethasone—Infection—Procarbazine—brain cancer	0.000956	0.00257	CcSEcCtD
Betamethasone—Hyperglycaemia—Carmustine—brain cancer	0.000955	0.00257	CcSEcCtD
Betamethasone—Angiopathy—Hydroxyurea—brain cancer	0.000951	0.00256	CcSEcCtD
Betamethasone—Shock—Procarbazine—brain cancer	0.000947	0.00255	CcSEcCtD
Betamethasone—Thrombocytopenia—Procarbazine—brain cancer	0.000942	0.00254	CcSEcCtD
Betamethasone—Tachycardia—Procarbazine—brain cancer	0.000939	0.00253	CcSEcCtD
Betamethasone—Weight increased—Temozolomide—brain cancer	0.000931	0.00251	CcSEcCtD
Betamethasone—Hyperhidrosis—Procarbazine—brain cancer	0.00093	0.0025	CcSEcCtD
Betamethasone—Alopecia—Hydroxyurea—brain cancer	0.000926	0.00249	CcSEcCtD
Betamethasone—Weight decreased—Temozolomide—brain cancer	0.000926	0.00249	CcSEcCtD
Betamethasone—Neuropathy peripheral—Carmustine—brain cancer	0.000925	0.00249	CcSEcCtD
Betamethasone—Hyperglycaemia—Temozolomide—brain cancer	0.000923	0.00248	CcSEcCtD
Betamethasone—Anorexia—Procarbazine—brain cancer	0.000917	0.00247	CcSEcCtD
Betamethasone—Erythema—Hydroxyurea—brain cancer	0.000912	0.00246	CcSEcCtD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000908	0.0169	CbGpPWpGaD
Betamethasone—Cardiac arrest—Etoposide—brain cancer	0.000901	0.00242	CcSEcCtD
Betamethasone—Nausea—Lomustine—brain cancer	0.0009	0.00242	CcSEcCtD
Betamethasone—NR3C1—endocrine gland—brain cancer	0.0009	0.00764	CbGeAlD
Betamethasone—PGR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0009	0.0167	CbGpPWpGaD
Betamethasone—Hypotension—Procarbazine—brain cancer	0.000899	0.00242	CcSEcCtD
Betamethasone—Neuropathy peripheral—Temozolomide—brain cancer	0.000894	0.00241	CcSEcCtD
Betamethasone—NR3C1—head—brain cancer	0.000889	0.00754	CbGeAlD
Betamethasone—PTGS2—midbrain—brain cancer	0.000887	0.00752	CbGeAlD
Betamethasone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000877	0.0163	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000877	0.00236	CcSEcCtD
Betamethasone—Insomnia—Procarbazine—brain cancer	0.00087	0.00234	CcSEcCtD
Betamethasone—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000866	0.0161	CbGpPWpGaD
Betamethasone—PTGS2—spinal cord—brain cancer	0.000865	0.00734	CbGeAlD
Betamethasone—Paraesthesia—Procarbazine—brain cancer	0.000864	0.00233	CcSEcCtD
Betamethasone—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.000857	0.0159	CbGpPWpGaD
Betamethasone—Haemoglobin—Carmustine—brain cancer	0.000852	0.00229	CcSEcCtD
Betamethasone—Haemorrhage—Carmustine—brain cancer	0.000847	0.00228	CcSEcCtD
Betamethasone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000847	0.00228	CcSEcCtD
Betamethasone—Hallucination—Carmustine—brain cancer	0.000843	0.00227	CcSEcCtD
Betamethasone—Decreased appetite—Procarbazine—brain cancer	0.000836	0.00225	CcSEcCtD
Betamethasone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000836	0.0155	CbGpPWpGaD
Betamethasone—Fatigue—Procarbazine—brain cancer	0.00083	0.00223	CcSEcCtD
Betamethasone—Haemoglobin—Temozolomide—brain cancer	0.000823	0.00221	CcSEcCtD
Betamethasone—Malaise—Hydroxyurea—brain cancer	0.000823	0.00221	CcSEcCtD
Betamethasone—Pain—Procarbazine—brain cancer	0.000823	0.00221	CcSEcCtD
Betamethasone—Haemorrhage—Temozolomide—brain cancer	0.000819	0.0022	CcSEcCtD
Betamethasone—Visual impairment—Carmustine—brain cancer	0.000817	0.0022	CcSEcCtD
Betamethasone—Hallucination—Temozolomide—brain cancer	0.000815	0.00219	CcSEcCtD
Betamethasone—NR3C1—central nervous system—brain cancer	0.000811	0.00688	CbGeAlD
Betamethasone—Sweating increased—Etoposide—brain cancer	0.000797	0.00215	CcSEcCtD
Betamethasone—PGR—Ovarian Infertility Genes—CDK4—brain cancer	0.000796	0.0148	CbGpPWpGaD
Betamethasone—Feeling abnormal—Procarbazine—brain cancer	0.000793	0.00213	CcSEcCtD
Betamethasone—NR3C1—cerebellum—brain cancer	0.000793	0.00673	CbGeAlD
Betamethasone—Eye disorder—Carmustine—brain cancer	0.000792	0.00213	CcSEcCtD
Betamethasone—Convulsion—Hydroxyurea—brain cancer	0.000791	0.00213	CcSEcCtD
Betamethasone—Visual impairment—Temozolomide—brain cancer	0.000789	0.00212	CcSEcCtD
Betamethasone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000787	0.0146	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Procarbazine—brain cancer	0.000787	0.00212	CcSEcCtD
Betamethasone—PTGS2—endocrine gland—brain cancer	0.000779	0.00661	CbGeAlD
Betamethasone—PTGS2—head—brain cancer	0.000769	0.00652	CbGeAlD
Betamethasone—Discomfort—Hydroxyurea—brain cancer	0.000768	0.00207	CcSEcCtD
Betamethasone—Eye disorder—Temozolomide—brain cancer	0.000765	0.00206	CcSEcCtD
Betamethasone—Urticaria—Procarbazine—brain cancer	0.000764	0.00206	CcSEcCtD
Betamethasone—ABCB1—telencephalon—brain cancer	0.000764	0.00648	CbGeAlD
Betamethasone—Abdominal pain—Procarbazine—brain cancer	0.000761	0.00205	CcSEcCtD
Betamethasone—Body temperature increased—Procarbazine—brain cancer	0.000761	0.00205	CcSEcCtD
Betamethasone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000757	0.0141	CbGpPWpGaD
Betamethasone—Arrhythmia—Carmustine—brain cancer	0.000757	0.00204	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000751	0.014	CbGpPWpGaD
Betamethasone—Alopecia—Carmustine—brain cancer	0.000749	0.00202	CcSEcCtD
Betamethasone—Oedema—Hydroxyurea—brain cancer	0.000745	0.002	CcSEcCtD
Betamethasone—Angiopathy—Temozolomide—brain cancer	0.000743	0.002	CcSEcCtD
Betamethasone—Infection—Hydroxyurea—brain cancer	0.00074	0.00199	CcSEcCtD
Betamethasone—Erythema—Carmustine—brain cancer	0.000738	0.00199	CcSEcCtD
Betamethasone—Nervous system disorder—Hydroxyurea—brain cancer	0.00073	0.00197	CcSEcCtD
Betamethasone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000729	0.00196	CcSEcCtD
Betamethasone—Alopecia—Temozolomide—brain cancer	0.000724	0.00195	CcSEcCtD
Betamethasone—Acute coronary syndrome—Etoposide—brain cancer	0.00072	0.00194	CcSEcCtD
Betamethasone—Neuropathy peripheral—Etoposide—brain cancer	0.000715	0.00193	CcSEcCtD
Betamethasone—Myocardial infarction—Etoposide—brain cancer	0.000715	0.00193	CcSEcCtD
Betamethasone—Erythema—Temozolomide—brain cancer	0.000713	0.00192	CcSEcCtD
Betamethasone—Anorexia—Hydroxyurea—brain cancer	0.00071	0.00191	CcSEcCtD
Betamethasone—PTGS2—central nervous system—brain cancer	0.000702	0.00596	CbGeAlD
Betamethasone—Asthenia—Procarbazine—brain cancer	0.00069	0.00186	CcSEcCtD
Betamethasone—PTGS2—cerebellum—brain cancer	0.000686	0.00582	CbGeAlD
Betamethasone—Pruritus—Procarbazine—brain cancer	0.000681	0.00183	CcSEcCtD
Betamethasone—CYP3A4—endocrine gland—brain cancer	0.000681	0.00578	CbGeAlD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000662	0.0123	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Temozolomide—brain cancer	0.000661	0.00178	CcSEcCtD
Betamethasone—Diarrhoea—Procarbazine—brain cancer	0.000658	0.00177	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.000658	0.0122	CbGpPWpGaD
Betamethasone—Dyspepsia—Hydroxyurea—brain cancer	0.000656	0.00176	CcSEcCtD
Betamethasone—Angioedema—Temozolomide—brain cancer	0.000651	0.00175	CcSEcCtD
Betamethasone—Decreased appetite—Hydroxyurea—brain cancer	0.000647	0.00174	CcSEcCtD
Betamethasone—NR3C1—brain—brain cancer	0.000644	0.00546	CbGeAlD
Betamethasone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000643	0.00173	CcSEcCtD
Betamethasone—Malaise—Temozolomide—brain cancer	0.000643	0.00173	CcSEcCtD
Betamethasone—Fatigue—Hydroxyurea—brain cancer	0.000642	0.00173	CcSEcCtD
Betamethasone—Vertigo—Temozolomide—brain cancer	0.00064	0.00172	CcSEcCtD
Betamethasone—Convulsion—Carmustine—brain cancer	0.000639	0.00172	CcSEcCtD
Betamethasone—ABCB1—gonad—brain cancer	0.000638	0.00541	CbGeAlD
Betamethasone—Hypertension—Carmustine—brain cancer	0.000637	0.00171	CcSEcCtD
Betamethasone—Pain—Hydroxyurea—brain cancer	0.000637	0.00171	CcSEcCtD
Betamethasone—Dizziness—Procarbazine—brain cancer	0.000636	0.00171	CcSEcCtD
Betamethasone—Myalgia—Carmustine—brain cancer	0.000628	0.00169	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—RELA—brain cancer	0.000627	0.0117	CbGpPWpGaD
Betamethasone—Anxiety—Carmustine—brain cancer	0.000626	0.00168	CcSEcCtD
Betamethasone—ABCB1—pituitary gland—brain cancer	0.000622	0.00528	CbGeAlD
Betamethasone—Convulsion—Temozolomide—brain cancer	0.000618	0.00166	CcSEcCtD
Betamethasone—Hypertension—Temozolomide—brain cancer	0.000615	0.00166	CcSEcCtD
Betamethasone—Feeling abnormal—Hydroxyurea—brain cancer	0.000614	0.00165	CcSEcCtD
Betamethasone—CYP3A4—central nervous system—brain cancer	0.000613	0.0052	CbGeAlD
Betamethasone—Eye disorder—Etoposide—brain cancer	0.000612	0.00165	CcSEcCtD
Betamethasone—Vomiting—Procarbazine—brain cancer	0.000612	0.00165	CcSEcCtD
Betamethasone—Myalgia—Temozolomide—brain cancer	0.000607	0.00163	CcSEcCtD
Betamethasone—Rash—Procarbazine—brain cancer	0.000607	0.00163	CcSEcCtD
Betamethasone—Dermatitis—Procarbazine—brain cancer	0.000606	0.00163	CcSEcCtD
Betamethasone—Anxiety—Temozolomide—brain cancer	0.000605	0.00163	CcSEcCtD
Betamethasone—Headache—Procarbazine—brain cancer	0.000603	0.00162	CcSEcCtD
Betamethasone—Oedema—Carmustine—brain cancer	0.000602	0.00162	CcSEcCtD
Betamethasone—ABCB1—medulla oblongata—brain cancer	0.0006	0.00509	CbGeAlD
Betamethasone—Discomfort—Temozolomide—brain cancer	0.0006	0.00161	CcSEcCtD
Betamethasone—Dexamethasone—CYP2C9—brain cancer	0.000599	0.0935	CrCbGaD
Betamethasone—Infection—Carmustine—brain cancer	0.000598	0.00161	CcSEcCtD
Betamethasone—Angiopathy—Etoposide—brain cancer	0.000595	0.0016	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—GFAP—brain cancer	0.000594	0.011	CbGpPWpGaD
Betamethasone—Thrombocytopenia—Carmustine—brain cancer	0.000589	0.00159	CcSEcCtD
Betamethasone—Body temperature increased—Hydroxyurea—brain cancer	0.000589	0.00158	CcSEcCtD
Betamethasone—Tachycardia—Carmustine—brain cancer	0.000588	0.00158	CcSEcCtD
Betamethasone—Oedema—Temozolomide—brain cancer	0.000582	0.00157	CcSEcCtD
Betamethasone—Anaphylactic shock—Temozolomide—brain cancer	0.000582	0.00157	CcSEcCtD
Betamethasone—Alopecia—Etoposide—brain cancer	0.000579	0.00156	CcSEcCtD
Betamethasone—Infection—Temozolomide—brain cancer	0.000578	0.00156	CcSEcCtD
Betamethasone—Anorexia—Carmustine—brain cancer	0.000574	0.00154	CcSEcCtD
Betamethasone—Nausea—Procarbazine—brain cancer	0.000572	0.00154	CcSEcCtD
Betamethasone—Nervous system disorder—Temozolomide—brain cancer	0.000571	0.00154	CcSEcCtD
Betamethasone—Thrombocytopenia—Temozolomide—brain cancer	0.00057	0.00153	CcSEcCtD
Betamethasone—Hypotension—Carmustine—brain cancer	0.000563	0.00151	CcSEcCtD
Betamethasone—Hyperhidrosis—Temozolomide—brain cancer	0.000562	0.00151	CcSEcCtD
Betamethasone—PTGS2—brain—brain cancer	0.000557	0.00473	CbGeAlD
Betamethasone—Anorexia—Temozolomide—brain cancer	0.000555	0.00149	CcSEcCtD
Betamethasone—ABCB1—midbrain—brain cancer	0.000549	0.00465	CbGeAlD
Betamethasone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000548	0.00148	CcSEcCtD
Betamethasone—Insomnia—Carmustine—brain cancer	0.000544	0.00147	CcSEcCtD
Betamethasone—Paraesthesia—Carmustine—brain cancer	0.000541	0.00145	CcSEcCtD
Betamethasone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000541	0.0101	CbGpPWpGaD
Betamethasone—ABCB1—spinal cord—brain cancer	0.000535	0.00454	CbGeAlD
Betamethasone—Asthenia—Hydroxyurea—brain cancer	0.000534	0.00144	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00053	0.00143	CcSEcCtD
Betamethasone—Ill-defined disorder—Etoposide—brain cancer	0.000529	0.00142	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000529	0.00984	CbGpPWpGaD
Betamethasone—Insomnia—Temozolomide—brain cancer	0.000526	0.00142	CcSEcCtD
Betamethasone—Decreased appetite—Carmustine—brain cancer	0.000523	0.00141	CcSEcCtD
Betamethasone—Paraesthesia—Temozolomide—brain cancer	0.000522	0.00141	CcSEcCtD
Betamethasone—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000522	0.00971	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00052	0.00968	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Carmustine—brain cancer	0.00052	0.0014	CcSEcCtD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000515	0.00958	CbGpPWpGaD
Betamethasone—Pain—Carmustine—brain cancer	0.000515	0.00139	CcSEcCtD
Betamethasone—Malaise—Etoposide—brain cancer	0.000514	0.00138	CcSEcCtD
Betamethasone—Vertigo—Etoposide—brain cancer	0.000512	0.00138	CcSEcCtD
Betamethasone—Dyspepsia—Temozolomide—brain cancer	0.000512	0.00138	CcSEcCtD
Betamethasone—Diarrhoea—Hydroxyurea—brain cancer	0.00051	0.00137	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000507	0.00944	CbGpPWpGaD
Betamethasone—Decreased appetite—Temozolomide—brain cancer	0.000506	0.00136	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000502	0.00135	CcSEcCtD
Betamethasone—Fatigue—Temozolomide—brain cancer	0.000502	0.00135	CcSEcCtD
Betamethasone—Loss of consciousness—Etoposide—brain cancer	0.000501	0.00135	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.0005	0.0093	CbGpPWpGaD
Betamethasone—Pain—Temozolomide—brain cancer	0.000497	0.00134	CcSEcCtD
Betamethasone—Feeling abnormal—Carmustine—brain cancer	0.000496	0.00134	CcSEcCtD
Betamethasone—Convulsion—Etoposide—brain cancer	0.000494	0.00133	CcSEcCtD
Betamethasone—Hypertension—Etoposide—brain cancer	0.000492	0.00133	CcSEcCtD
Betamethasone—Dizziness—Hydroxyurea—brain cancer	0.000492	0.00133	CcSEcCtD
Betamethasone—Gastrointestinal pain—Carmustine—brain cancer	0.000492	0.00132	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000482	0.00897	CbGpPWpGaD
Betamethasone—ABCB1—endocrine gland—brain cancer	0.000482	0.00409	CbGeAlD
Betamethasone—Discomfort—Etoposide—brain cancer	0.00048	0.00129	CcSEcCtD
Betamethasone—Feeling abnormal—Temozolomide—brain cancer	0.000479	0.00129	CcSEcCtD
Betamethasone—Body temperature increased—Carmustine—brain cancer	0.000476	0.00128	CcSEcCtD
Betamethasone—Abdominal pain—Carmustine—brain cancer	0.000476	0.00128	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000476	0.00885	CbGpPWpGaD
Betamethasone—ABCB1—head—brain cancer	0.000476	0.00404	CbGeAlD
Betamethasone—Gastrointestinal pain—Temozolomide—brain cancer	0.000476	0.00128	CcSEcCtD
Betamethasone—Vomiting—Hydroxyurea—brain cancer	0.000473	0.00127	CcSEcCtD
Betamethasone—Rash—Hydroxyurea—brain cancer	0.00047	0.00126	CcSEcCtD
Betamethasone—Dermatitis—Hydroxyurea—brain cancer	0.000469	0.00126	CcSEcCtD
Betamethasone—Headache—Hydroxyurea—brain cancer	0.000467	0.00126	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—brain cancer	0.000466	0.00125	CcSEcCtD
Betamethasone—Infection—Etoposide—brain cancer	0.000462	0.00124	CcSEcCtD
Betamethasone—Urticaria—Temozolomide—brain cancer	0.000462	0.00124	CcSEcCtD
Betamethasone—Abdominal pain—Temozolomide—brain cancer	0.00046	0.00124	CcSEcCtD
Betamethasone—Body temperature increased—Temozolomide—brain cancer	0.00046	0.00124	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—brain cancer	0.000456	0.00123	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—brain cancer	0.000454	0.00122	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—brain cancer	0.00045	0.00121	CcSEcCtD
Betamethasone—Anorexia—Etoposide—brain cancer	0.000444	0.00119	CcSEcCtD
Betamethasone—Nausea—Hydroxyurea—brain cancer	0.000442	0.00119	CcSEcCtD
Betamethasone—Hypotension—Etoposide—brain cancer	0.000435	0.00117	CcSEcCtD
Betamethasone—ABCB1—central nervous system—brain cancer	0.000434	0.00368	CbGeAlD
Betamethasone—Asthenia—Carmustine—brain cancer	0.000432	0.00116	CcSEcCtD
Betamethasone—ABCB1—cerebellum—brain cancer	0.000424	0.0036	CbGeAlD
Betamethasone—Paraesthesia—Etoposide—brain cancer	0.000418	0.00112	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—PIK3CG—brain cancer	0.000418	0.00777	CbGpPWpGaD
Betamethasone—Asthenia—Temozolomide—brain cancer	0.000417	0.00112	CcSEcCtD
Betamethasone—Diarrhoea—Carmustine—brain cancer	0.000412	0.00111	CcSEcCtD
Betamethasone—Pruritus—Temozolomide—brain cancer	0.000412	0.00111	CcSEcCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000406	0.00756	CbGpPWpGaD
Betamethasone—Decreased appetite—Etoposide—brain cancer	0.000405	0.00109	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—brain cancer	0.000402	0.00108	CcSEcCtD
Betamethasone—Fatigue—Etoposide—brain cancer	0.000401	0.00108	CcSEcCtD
Betamethasone—Dizziness—Carmustine—brain cancer	0.000398	0.00107	CcSEcCtD
Betamethasone—Pain—Etoposide—brain cancer	0.000398	0.00107	CcSEcCtD
Betamethasone—Diarrhoea—Temozolomide—brain cancer	0.000398	0.00107	CcSEcCtD
Betamethasone—Dizziness—Temozolomide—brain cancer	0.000385	0.00104	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—brain cancer	0.000384	0.00103	CcSEcCtD
Betamethasone—Vomiting—Carmustine—brain cancer	0.000383	0.00103	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—brain cancer	0.000381	0.00102	CcSEcCtD
Betamethasone—Rash—Carmustine—brain cancer	0.00038	0.00102	CcSEcCtD
Betamethasone—Dermatitis—Carmustine—brain cancer	0.000379	0.00102	CcSEcCtD
Betamethasone—Headache—Carmustine—brain cancer	0.000377	0.00101	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000371	0.0069	CbGpPWpGaD
Betamethasone—Vomiting—Temozolomide—brain cancer	0.00037	0.000995	CcSEcCtD
Betamethasone—Urticaria—Etoposide—brain cancer	0.00037	0.000995	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—brain cancer	0.000368	0.00099	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—brain cancer	0.000368	0.00099	CcSEcCtD
Betamethasone—Rash—Temozolomide—brain cancer	0.000367	0.000987	CcSEcCtD
Betamethasone—Dermatitis—Temozolomide—brain cancer	0.000366	0.000986	CcSEcCtD
Betamethasone—Headache—Temozolomide—brain cancer	0.000364	0.000981	CcSEcCtD
Betamethasone—Nausea—Carmustine—brain cancer	0.000358	0.000962	CcSEcCtD
Betamethasone—Nausea—Temozolomide—brain cancer	0.000346	0.00093	CcSEcCtD
Betamethasone—ABCB1—brain—brain cancer	0.000345	0.00292	CbGeAlD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000342	0.00636	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000342	0.00636	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—VAV1—brain cancer	0.000339	0.00631	CbGpPWpGaD
Betamethasone—Asthenia—Etoposide—brain cancer	0.000334	0.000899	CcSEcCtD
Betamethasone—Pruritus—Etoposide—brain cancer	0.000329	0.000886	CcSEcCtD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000327	0.00608	CbGpPWpGaD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000323	0.006	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000319	0.00593	CbGpPWpGaD
Betamethasone—Diarrhoea—Etoposide—brain cancer	0.000319	0.000857	CcSEcCtD
Betamethasone—Dizziness—Etoposide—brain cancer	0.000308	0.000828	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000305	0.00567	CbGpPWpGaD
Betamethasone—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000298	0.00554	CbGpPWpGaD
Betamethasone—Vomiting—Etoposide—brain cancer	0.000296	0.000797	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000295	0.00549	CbGpPWpGaD
Betamethasone—Rash—Etoposide—brain cancer	0.000294	0.00079	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—brain cancer	0.000293	0.000789	CcSEcCtD
Betamethasone—Headache—Etoposide—brain cancer	0.000292	0.000785	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000279	0.0052	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.000278	0.00517	CbGpPWpGaD
Betamethasone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000278	0.00517	CbGpPWpGaD
Betamethasone—Nausea—Etoposide—brain cancer	0.000277	0.000744	CcSEcCtD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000265	0.00493	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	0.000255	0.00475	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.00025	0.00465	CbGpPWpGaD
Betamethasone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000246	0.00458	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000244	0.00454	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IRS2—brain cancer	0.000244	0.00454	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	0.000242	0.0045	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000237	0.00441	CbGpPWpGaD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000237	0.0044	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP2C9—brain cancer	0.000226	0.0042	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000219	0.00407	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000213	0.00397	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000213	0.00396	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000205	0.00382	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000203	0.00378	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000199	0.00371	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.000198	0.00367	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—BSG—brain cancer	0.000192	0.00357	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000192	0.00357	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000188	0.0035	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000185	0.00345	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—OR14C36—brain cancer	0.000183	0.00341	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—OR4C12—brain cancer	0.000183	0.00341	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000171	0.00319	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.000167	0.00311	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—IDH1—brain cancer	0.000165	0.00307	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000165	0.00307	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000163	0.00303	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000162	0.00302	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000162	0.00301	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000161	0.00299	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IRS2—brain cancer	0.00016	0.00297	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000159	0.00296	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000159	0.00295	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000157	0.00293	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—DTX2—brain cancer	0.000156	0.0029	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000155	0.00289	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000151	0.00281	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000147	0.00274	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000147	0.00273	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000146	0.00271	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000144	0.00267	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000141	0.00262	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000139	0.00258	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	0.000138	0.00257	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000137	0.00255	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—DNMT1—brain cancer	0.000137	0.00255	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000135	0.00252	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000135	0.00251	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000135	0.0025	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000132	0.00246	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ENO2—brain cancer	0.000131	0.00243	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.000127	0.00237	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000124	0.0023	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	0.000123	0.00229	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR2—brain cancer	0.000123	0.00229	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDK4—brain cancer	0.000123	0.00228	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000121	0.00226	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTCH2—brain cancer	0.000118	0.0022	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NOTCH2—brain cancer	0.000116	0.00217	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000116	0.00216	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000115	0.00214	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HES5—brain cancer	0.000114	0.00213	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	0.000114	0.00212	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000113	0.00211	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000113	0.00209	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STRADA—brain cancer	0.000111	0.00206	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00011	0.00205	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000109	0.00203	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000105	0.00195	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	0.000104	0.00194	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000101	0.00189	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000101	0.00187	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SIRT1—brain cancer	9.9e-05	0.00184	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DTX2—brain cancer	9.74e-05	0.00181	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	9.74e-05	0.00181	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.72e-05	0.00181	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	9.66e-05	0.0018	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	9.64e-05	0.00179	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—CTNNB1—brain cancer	9.58e-05	0.00178	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ABR—brain cancer	9.26e-05	0.00172	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	9.22e-05	0.00171	CbGpPWpGaD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.1e-05	0.00169	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.05e-05	0.00168	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	8.99e-05	0.00167	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GLI2—brain cancer	8.95e-05	0.00166	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	8.51e-05	0.00158	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	8.49e-05	0.00158	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GLI1—brain cancer	8.41e-05	0.00156	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—STAT3—brain cancer	8.35e-05	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	8.35e-05	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	8.34e-05	0.00155	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—DNMT1—brain cancer	8.34e-05	0.00155	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.28e-05	0.00154	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP2C9—brain cancer	8.25e-05	0.00153	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL2—brain cancer	8.13e-05	0.00151	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—brain cancer	8.05e-05	0.0015	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	7.98e-05	0.00148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SUFU—brain cancer	7.97e-05	0.00148	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL2—brain cancer	7.94e-05	0.00148	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	7.93e-05	0.00147	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.86e-05	0.00146	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	7.83e-05	0.00146	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	7.81e-05	0.00145	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	7.8e-05	0.00145	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.73e-05	0.00144	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GFAP—brain cancer	7.69e-05	0.00143	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	7.64e-05	0.00142	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR2—brain cancer	7.48e-05	0.00139	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HEY1—brain cancer	7.29e-05	0.00136	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.29e-05	0.00136	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.19e-05	0.00134	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—DLL1—brain cancer	7.15e-05	0.00133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES5—brain cancer	7.15e-05	0.00133	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH2—brain cancer	7.09e-05	0.00132	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BSG—brain cancer	7.01e-05	0.0013	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	6.85e-05	0.00127	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—brain cancer	6.75e-05	0.00126	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	6.41e-05	0.00119	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—brain cancer	6.36e-05	0.00118	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	6.22e-05	0.00116	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.1e-05	0.00114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SHH—brain cancer	6.08e-05	0.00113	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—IDH1—brain cancer	6.03e-05	0.00112	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SIRT1—brain cancer	6.03e-05	0.00112	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CG—brain cancer	5.99e-05	0.00111	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.92e-05	0.0011	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TRPC6—brain cancer	5.86e-05	0.00109	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMO—brain cancer	5.77e-05	0.00107	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTCH1—brain cancer	5.77e-05	0.00107	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.57e-05	0.00104	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2C9—brain cancer	5.51e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.39e-05	0.001	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.34e-05	0.000993	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—brain cancer	5.22e-05	0.000971	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.91e-05	0.000914	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—brain cancer	4.9e-05	0.000912	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—DNMT1—brain cancer	4.82e-05	0.000896	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IDH1—brain cancer	4.81e-05	0.000895	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ENO2—brain cancer	4.77e-05	0.000887	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.7e-05	0.000874	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BSG—brain cancer	4.69e-05	0.000872	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.65e-05	0.000865	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH2—brain cancer	4.61e-05	0.000857	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEY1—brain cancer	4.56e-05	0.000849	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DLL1—brain cancer	4.47e-05	0.000832	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VAV1—brain cancer	4.39e-05	0.000817	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR2—brain cancer	4.33e-05	0.000805	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.33e-05	0.000805	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.32e-05	0.000804	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.23e-05	0.000787	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH2—brain cancer	4.1e-05	0.000762	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—IDH1—brain cancer	4.03e-05	0.00075	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2C9—brain cancer	3.91e-05	0.000727	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—brain cancer	3.88e-05	0.000721	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.82e-05	0.000711	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SHH—brain cancer	3.8e-05	0.000708	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ENO2—brain cancer	3.8e-05	0.000708	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.78e-05	0.000704	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HES1—brain cancer	3.78e-05	0.000703	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDGFRA—brain cancer	3.6e-05	0.000669	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.55e-05	0.000661	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—brain cancer	3.49e-05	0.00065	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SIRT1—brain cancer	3.48e-05	0.000648	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.33e-05	0.00062	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BSG—brain cancer	3.32e-05	0.000618	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.28e-05	0.000611	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ENO2—brain cancer	3.19e-05	0.000593	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS2—brain cancer	3.16e-05	0.000588	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.07e-05	0.00057	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3e-05	0.000558	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IDH1—brain cancer	2.86e-05	0.000532	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	2.83e-05	0.000527	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—brain cancer	2.79e-05	0.000519	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—brain cancer	2.79e-05	0.000519	CbGpPWpGaD
Betamethasone—PTGS2—Disease—VAV1—brain cancer	2.75e-05	0.000511	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.52e-05	0.000468	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2C9—brain cancer	2.41e-05	0.000448	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES1—brain cancer	2.36e-05	0.00044	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—brain cancer	2.36e-05	0.000439	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO2—brain cancer	2.26e-05	0.00042	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRA—brain cancer	2.25e-05	0.000419	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—brain cancer	2.19e-05	0.000407	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RELA—brain cancer	2.18e-05	0.000406	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—brain cancer	2.17e-05	0.000403	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BSG—brain cancer	2.05e-05	0.000381	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS2—brain cancer	1.98e-05	0.000368	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—brain cancer	1.96e-05	0.000365	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—brain cancer	1.91e-05	0.000356	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—brain cancer	1.9e-05	0.000353	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH1—brain cancer	1.76e-05	0.000327	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—brain cancer	1.75e-05	0.000325	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—brain cancer	1.67e-05	0.00031	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—brain cancer	1.65e-05	0.000307	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—brain cancer	1.54e-05	0.000286	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—brain cancer	1.5e-05	0.000279	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—brain cancer	1.46e-05	0.000272	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO2—brain cancer	1.39e-05	0.000259	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—brain cancer	1.36e-05	0.000254	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—brain cancer	1.36e-05	0.000252	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—brain cancer	1.26e-05	0.000235	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—brain cancer	1.19e-05	0.000221	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—brain cancer	1.04e-05	0.000193	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—brain cancer	1.03e-05	0.000192	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—brain cancer	9.6e-06	0.000179	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—brain cancer	9.39e-06	0.000175	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—brain cancer	6.38e-06	0.000119	CbGpPWpGaD
